The United Kingdom stands as a global titan in life sciences, anchored by the "Golden Triangle" of London, Cambridge, and Oxford. Following the implementation of the O’Shaughnessy Review and the Lord O'Shaughnessy independent review into commercial clinical trials, the UK government has prioritized the integration of Decentralized Clinical Trial (DCT) solutions into the National Health Service (NHS).
For manufacturers and exporters like Dongguan Trial Medical Co., Ltd., the UK market represents a sophisticated environment where "Information Gain" and high-fidelity data are non-negotiable. Our decentralized solutions align perfectly with the UK's Life Sciences Vision, focusing on remote patient monitoring, wearable integration, and reduced site burden, which is critical for the NHS's digital transformation goals.
Dongguan Trial Medical Co., Ltd. is a specialized manufacturer of remote clinical trial monitoring devices, decentralized clinical trial solutions, and digital research technologies. Established in 2016, the company is located in Dongguan, China, a major center for advanced manufacturing, medical technology development, and electronic innovation.
Operating from a modern facility covering more than 11,000 square meters, with a team of over 230 employees, Trial Medical is dedicated to developing and manufacturing innovative technologies that support clinical research organizations (CROs), pharmaceutical companies, healthcare institutions, and academic research centers worldwide.
The company's product portfolio includes remote clinical trial monitoring devices, wearable health data collection systems, patient engagement platforms, electronic clinical outcome assessment (eCOA) solutions, digital research tools, remote safety monitoring systems, and decentralized trial support technologies. These solutions are designed to facilitate real-time data collection, improve participant engagement, streamline study management, and enhance operational efficiency throughout the clinical research process.
Utilizing predictive analytics to identify patient non-compliance before it impacts trial data integrity. For UK investigators, this means higher confidence in Real World Evidence (RWE).
Processing patient vitals locally on the device to ensure low latency and high security, compliant with UK-GDPR and Cyber Essentials Plus standards.
Seamless API integration with NHS Digital systems and major CRO platforms like Medidata and Veeva, ensuring a unified data stream from patient to sponsor.
Globally, the decentralization of clinical trials has shifted from a "pandemic necessity" to a "strategic imperative." In the United Kingdom, the Medicines and Healthcare products Regulatory Agency (MHRA) has been a pioneer in providing guidance for decentralized components. Our solutions address the specific UK need for "inclusive trials," allowing patients from rural areas (from the Scottish Highlands to Cornwall) to participate in life-saving research without the need for frequent travel to urban centers like London or Manchester.
Supported by an experienced team of engineers, software developers, and quality management professionals, Trial Medical continuously invests in research and development to address the evolving needs of modern clinical studies. The company integrates advanced connectivity technologies, cloud-based data management capabilities, and intelligent monitoring functions to support reliable and scalable clinical research operations.
Comprehensive quality control procedures are implemented across product design, manufacturing, testing, and inspection processes to ensure consistent performance and product reliability. In addition to its standard product offerings, the company provides OEM and ODM services tailored to specific research applications and market requirements in the United Kingdom.
Serving customers across North America, Europe, Asia-Pacific, the Middle East, Latin America, and Africa, Dongguan Trial Medical Co., Ltd. is committed to advancing digital clinical research through innovative technologies that support decentralized studies, patient-centric trial models, and data-driven healthcare innovation worldwide.
Yes, our hardware and software architectures are designed to support data integrity standards (ALCOA+) and are adaptable to MHRA’s "GXP" requirements, ensuring that remote data collection meets the same rigorous standards as on-site clinical visits.
Our digital research tools utilize end-to-end encryption and are compatible with UK-GDPR protocols. We provide localized data hosting options and rigorous access controls to protect Patient Identifiable Information (PII).
Absolutely. We have a 11,000 square meter facility dedicated to OEM/ODM, allowing UK sponsors to customize wearable devices and software interfaces to match their specific study protocols and branding.
With our established logistics network for the European market, standard reagents and cleaning solutions typically reach UK hubs within 7-12 business days, pending customs clearance.
Partner with a manufacturer that understands the nuances of the British life sciences sector.
Send Inquiry Now
Trial Medical
